Market Cap 922.66M
Revenue (ttm) 1.02B
Net Income (ttm) -47.10M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE 28.09
Profit Margin -4.60%
Debt to Equity Ratio 0.00
Volume 315,716
Avg Vol 953,072
Day's Range N/A - N/A
Shares Out 96.11M
Stochastic %K 51%
Beta N/A
Analysts Strong Sell
Price Target $19.29

Company Profile

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States. The company provides outpatient medical imaging services, such as magnetic resonance imaging (MRI), computed tomography (CT), and positron emission tomography (PET) services, as well as X-ray, ultrasound, and mammography diagnostic and screening imaging services. Lumexa Imaging Holdings, Inc. was founded in 2018 and is based in Raleigh, North Carolina.

Industry: Medical Devices
Sector: Healthcare
Phone: 919 763 1100
Address:
4200 Six Forks Road, Suite 1000, Raleigh, United States
Latest News on LMRI
Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer

Apr 20, 2026, 7:00 AM EDT - 7 days ago

Lumexa Imaging Appoints Kyle Lynch as Chief Growth Officer


Lumexa Imaging Holdings Earnings Call Transcript: Q4 2025

Mar 26, 2026, 8:30 AM EDT - 4 weeks ago

Lumexa Imaging Holdings Earnings Call Transcript: Q4 2025


Lumexa Imaging Achieves Record De Novo Expansion in 2025

Jan 8, 2026, 7:00 AM EST - 3 months ago

Lumexa Imaging Achieves Record De Novo Expansion in 2025


Welsh Carson-backed Lumexa Imaging raises $463 million in US IPO

Dec 10, 2025, 6:26 PM EST - 4 months ago

Welsh Carson-backed Lumexa Imaging raises $463 million in US IPO


Lumexa Imaging Announces Pricing of Initial Public Offering

Dec 10, 2025, 6:01 PM EST - 4 months ago

Lumexa Imaging Announces Pricing of Initial Public Offering


Lumexa Imaging targets up to $1.89 billion valuation in US IPO

Dec 2, 2025, 6:54 AM EST - 5 months ago

Lumexa Imaging targets up to $1.89 billion valuation in US IPO


Lumexa Imaging IPO Registration Document (S-1)

Nov 17, 2025, 4:24 PM EST - 5 months ago

Lumexa Imaging IPO Registration Document (S-1)